Psychiatry Grand Rounds: Recovery Oriented Cognitive Therapy for Schizophrenia

Presenter: Aaron Brinen, PsyD
Clinical Associate, Department of Psychiatry
University of Pennsylvania

Tuesday, August 8, 2017
11 a.m. – 12:30 p.m.
Dean’s Conference Room                                                           
E & R Building
Camden

The learner objectives for this activity are to improve diagnostic skills, increase knowledge of all psychiatric disorders, and discuss recent advances in all areas of psychiatry, psychopharmacology, psychotherapy, and evaluative techniques.… Read more.

Psychiatry Grand Rounds: Synthetic Cannabinoids: An Emerging Epidemic?

Synthetic cannabinoids comprise the largest class of emerging novel psychoactive substances. This grand rounds presentation will provide a broad overview of the clinical and public health implications of the synthetic cannabinoid “epidemic,” and will review the results of a study describing sociodemographic correlates and clinical effects of synthetic cannabinoid use in a population with serious mental illness.… Read more.

Cooper Photo of the Week

Scott says, “Cool pic taken from the Federal Reserve Building in Philadelphia. Look closely and you’ll see what’s at the end of the rainbow … Cooper’s (Roberts) Pavilion building.”

We welcome your photos!

Share your Cooper photos like a sunset from the helipad or a selfie on your unit by tagging @cooperuniversityhealthcare in your Instagram posts.… Read more.

Dan Gottlieb and Dr. Sabia Present: Focus on Pain

Dan Gottlieb, PhD, host of Voices in the Family, and Cooper’s own pain management expert Michael Sabia, MD, will discuss Focus on Pain. The talk show, which was recorded earlier at Cooper Medical School of Rowan University in front of a live audience, will air on WHYY FM on Sunday, July 23, 2017, at 8 p.m.… Read more.

FDA Grants Clearance for Z-Medica’s QuikClot

Z-Medica, LLC announces that QuikClot® Control+™ has been cleared for use by the U.S. Food and Drug Administration (FDA) under the de novo classification process and is designated as a Class II medical device.

For those of you who are familiar with TraumaPads, this is the next generation of the product where the active ingredient is bonded to the woven sponge, resulting in easier removal from the abdominal cavity as well as zero chance of kaolin embolization.… Read more.